Search Results 781-790 of 17087 for treatment resistant depression

  1. Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy - Mayo Clinic

    Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy.

  2. Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) - Mayo Clinic

    Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) · Overview · Participation eligibility · Participating Mayo ...

  3. Sumatriptan and naproxen (oral route) - Side effects & dosage - Mayo Clinic

    This especially includes medicines used to treat depression, including citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, olanzapine, paroxetine ...

  4. Psychiatry and Psychology - Doctors - Mayo Clinic

    Allen, M.D.. Psychiatrist. Rochester, MN. Areas of focus: Electroconvulsive therapy, Delirium, Neurocognitive disorder, Depression, Anxiety disorder, Bipolar ...

  5. A Study to Evaluate the Effectiveness and Safety of Ibrexafungerp in Patients with Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment - Mayo Clinic

    About this study. The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of ...

  6. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

  7. Hematology - Clinical trials

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  8. Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.

  9. Hematology - Clinical trials

    ... resistant chronic lymphocytic leukemia. Patients ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...

  10. Joel Streed | Mayo Clinic News Network - Page 68 of 170

    Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio. As summer vacation rolls on ...